MedPath

microRNAs Role in Pre-eclampsia Diagnosis

Completed
Conditions
Preeclampsia
Registration Number
NCT03562715
Lead Sponsor
Cairo University
Brief Summary

Pre-eclampsia is one of the most threatening pregnancy complications. So far neither a secure, competent therapy for PE nor effective biomarkers for a premature discovery has been achieved.The aim of our study was to identify miRNAs 136, 494 and 495 genes expression in exosomes of peripheral blood compared to umbilical cord mesenchymal stem cells conditioned media released exososomes in patients with PE, as valuable markers for PE early prediction.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
200
Inclusion Criteria

To have an uncomplicated pregnancy:

  1. gestational age at venipuncture between 20 - 42 weeks
  2. no medical, obstetrical, or surgical complications
  3. absence of labor at the time of venipuncture
  4. delivery of a normal term (≥ 37 weeks) neonate whose birth weight was between the 10th and 90th percentile for gestational age
Read More
Exclusion Criteria

Patients with chronic hypertension, renal disease, and fetuses affected with congenital anomalies were excluded

Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The expression of miRNAs 136, 494 and 495 in exosomes of peripheral blood and UCMSCs conditioned media2-3 months
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath